BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

NanoLogix, Inc. 

843 North Main Street

Hubbard  Ohio  44425  U.S.A.
Phone: 330-534-0800 Fax: 330-534-0826


SEARCH JOBS




Industry
Biotechnology






 Company News
NanoLogix, Inc. (NNLX) Sets New Standard For Extended Shelf Life Of Petri-Plates 2/24/2014 8:33:41 AM    More...
NanoLogix, Inc. (NNLX) And Saudi Company To Work Together For Distribution Of NanoLogix Products In The Arabian Gulf Region 12/4/2013 9:05:21 AM    More...
EPA and NanoLogix, Inc. (NNLX) to Extend Agreement to 2015 6/11/2013 10:02:27 AM    More...
NanoLogix, Inc. (NNLX) to Exhibit at Food Safety Summit in Baltimore and American Society for Microbiology Annual Meeting in Denver 4/30/2013 6:57:53 AM    More...
University of Texas Health Science Center at Houston Releases News of Successful NanoLogix, Inc. (NNLX) Test 3/12/2013 9:31:18 AM    More...
NanoLogix, Inc. (NNLX) Rapid TB Detection Results Published in Journal of Microbial & Biochemical Technology 12/17/2012 9:56:30 AM    More...
NanoLogix, Inc. (NNLX) Rapid Diagnostic Technologies Set to Enter Market Under FDA 510K-Exempt Status 8/21/2012 9:31:02 AM    More...
NanoLogix, Inc. (NNLX) Featured in USA Today Group B Streptococcus (GBS) Awareness Campaign 8/1/2012 12:01:07 PM    More...
NanoLogix, Inc. (NNLX) Announces Development of Multi-Well, Rapid Diagnostic Test Variant and Exhibits at the American Society for Microbiology General Meeting in San Francisco 6/13/2012 10:23:21 AM    More...
NanoLogix, Inc. (NNLX) Provides Testing and Operations Update 4/24/2012 10:17:31 AM    More...
1234567